Real‐World Effectiveness and Safety of Mepolizumab in Pediatric Severe Eosinophilic Asthma: A Multicenter Study
Mepolizumab showed sustained effectiveness and good tolerability in pediatric SEA, significantly reducing exacerbations and OCS use while improving asthma control and lung function. These findings support its real-world utility and underscore the need for careful patient selection and monitoring.
Authors
- Melike Ocak (ORCID: https://orcid.org/0000-0001-7841-4690)
- Mahir Serbes (ORCID: https://orcid.org/0000-0001-6422-2639)
- N Cevik (ORCID: https://orcid.org/0000-0002-0621-4312)
- Alev Bingöl
- Gaye Kocatepe
- Dilek Ozcan
- Bulent Enis Sekerel
- Nilgün Bahar Teker
Institutions
- Akdeniz University (TR)
- Cukurova University (TR)
- Hacettepe University (TR)
Publication Details
- Journal
- Pediatric Pulmonology
- Published
- 2026-01-01
- DOI
- https://doi.org/10.1002/ppul.71466
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00